These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3100761)

  • 1. Treatment of trypanosome-infected mice with exogenous interferon, interferon inducers, or antibody to interferon.
    DeGee AL; Mansfield JM; Sonnenfeld G
    J Parasitol; 1986 Oct; 72(5):792-4. PubMed ID: 3100761
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetics of resistance to the African trypanosomes. III. Variant-specific antibody responses of H-2-compatible resistant and susceptible mice.
    Levine RF; Mansfield JM
    J Immunol; 1984 Sep; 133(3):1564-9. PubMed ID: 6747297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental murine Trypanosoma congolense infections. I. Administration of anti-IFN-gamma antibodies alters trypanosome-susceptible mice to a resistant-like phenotype.
    Uzonna JE; Kaushik RS; Gordon JR; Tabel H
    J Immunol; 1998 Nov; 161(10):5507-15. PubMed ID: 9820527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis.
    Barkhuizen M; Magez S; Atkinson RA; Brombacher F
    J Infect Dis; 2007 Oct; 196(8):1253-60. PubMed ID: 17955445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis.
    Hertz CJ; Mansfield JM
    Cell Immunol; 1999 Feb; 192(1):24-32. PubMed ID: 10066343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to the African trypanosomes is IFN-gamma dependent.
    Hertz CJ; Filutowicz H; Mansfield JM
    J Immunol; 1998 Dec; 161(12):6775-83. PubMed ID: 9862708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The susceptibility of strains of mice to infection with Trypanosoma congolense.
    Jennings FW; Whitelaw DD; Holmes PH; Urquhart GM
    Res Vet Sci; 1978 Nov; 25(3):399-400. PubMed ID: 749094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inheritance of factors controlling resistance in mice infected with Trypanosoma brucei rhodesiense.
    Seed JR; Sechelski J
    J Parasitol; 1995 Aug; 81(4):653-7. PubMed ID: 7623216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice.
    Kaushik RS; Uzonna JE; Zhang Y; Gordon JR; Tabel H
    Cytokine; 2000 Jul; 12(7):1024-34. PubMed ID: 10880248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate resistance to Trypanosoma congolense infections: differential production of nitric oxide by macrophages from susceptible BALB/c and resistant C57Bl/6 mice.
    Kaushik RS; Uzonna JE; Gordon JR; Tabel H
    Exp Parasitol; 1999 Jun; 92(2):131-43. PubMed ID: 10366538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses.
    De Gee AL; Levine RF; Mansfield JM
    J Immunol; 1988 Jan; 140(1):283-8. PubMed ID: 3121739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interferons during experimental African trypanosomiasis.
    Bancroft GJ; Sutton CJ; Morris AG; Askonas BA
    Clin Exp Immunol; 1983 Apr; 52(1):135-43. PubMed ID: 6190591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis.
    Gómez-Rodríguez J; Stijlemans B; De Muylder G; Korf H; Brys L; Berberof M; Darji A; Pays E; De Baetselier P; Beschin A
    J Infect Dis; 2009 Dec; 200(12):1849-60. PubMed ID: 19911988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental African trypanosomiasis: IFN-gamma mediates early mortality.
    Shi M; Pan W; Tabel H
    Eur J Immunol; 2003 Jan; 33(1):108-18. PubMed ID: 12594839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1 and interleukin-2 production in resistant and susceptible inbred mice infected with Trypanosoma congolense.
    Mitchell LA; Pearson TW; Gauldie J
    Immunology; 1986 Feb; 57(2):291-6. PubMed ID: 3485076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Defense mechanisms in trypanosomiasis].
    Daulouede PS; Okomo-Assoumou MC; Labassa M; Fouquet C; Vincendeau P
    Bull Soc Pathol Exot; 1994; 87(5):330-2. PubMed ID: 7496195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
    Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
    J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of antibody in African trypanosomiasis.
    Seed JR; Sechelski J
    J Parasitol; 1987 Aug; 73(4):840-2. PubMed ID: 3625434
    [No Abstract]   [Full Text] [Related]  

  • 19. P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis.
    Magez S; Truyens C; Merimi M; Radwanska M; Stijlemans B; Brouckaert P; Brombacher F; Pays E; De Baetselier P
    J Infect Dis; 2004 Feb; 189(3):527-39. PubMed ID: 14745712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses in resistant and susceptible inbred mice infected with Trypanosoma congolense.
    Mitchell LA; Pearson TW
    Immunology; 1986 Feb; 57(2):297-303. PubMed ID: 3949371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.